Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -27.25% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 139.68% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 25.99% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 41.58% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 85.94% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.28% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.43% |
| Jun 30, 2025 | 23.21% |
| Mar 31, 2025 | 14.96% |
| Dec 31, 2024 | 58.79% |
| Sep 30, 2024 | -285.97% |
| Jun 30, 2024 | -81.71% |
| Mar 31, 2024 | -80.99% |
| Dec 31, 2023 | -229.58% |
| Sep 30, 2023 | -74.12% |
| Jun 30, 2023 | -57.97% |
| Mar 31, 2023 | -114.44% |
| Dec 31, 2022 | -85.10% |
| Sep 30, 2022 | -87.52% |
| Jun 30, 2022 | -376.22% |
| Mar 31, 2022 | -73.87% |
| Dec 31, 2021 | -227.21% |
| Sep 30, 2021 | 57.47% |
| Jun 30, 2021 | 10.61% |
| Mar 31, 2021 | 12.64% |
| Dec 31, 2020 | 37.00% |